Literature DB >> 12624136

Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism.

Y J Crow1, D N Black, M Ali, J Bond, A P Jackson, M Lefson, J Michaud, E Roberts, J B P Stephenson, C G Woods, P Lebon.   

Abstract

Aicardi-Goutiéres syndrome (AGS) is an early onset, progressive encephalopathy characterised by calcification of the basal ganglia, white matter abnormalities, and a chronic cerebrospinal fluid (CSF) lymphocytosis. Cree encephalitis shows phenotypic overlap with AGS although the conditions have been considered distinct because of immunological abnormalities observed in Cree encephalitis. We report that levels of interferon alpha (IFN-alpha), a marker of AGS, are raised in Cree encephalitis. Moreover, linkage analysis indicates that the disorders are allelic and refines the AGS1 locus to a 3.47 cM critical interval. Our data show that a CSF lymphocytosis is not necessary for the diagnosis of AGS and strongly suggest that AGS and pseudo-TORCH syndrome are the same disorder. Recognition of immunological dysfunction as part of the AGS phenotype provides further evidence of a primary pathogenic role for abnormal IFN-alpha production in AGS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624136      PMCID: PMC1735395          DOI: 10.1136/jmg.40.3.183

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  39 in total

1.  Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2.

Authors:  Luna Alammar Zaritsky; Lucio Gama; Janice E Clements
Journal:  J Immunol       Date:  2012-03-09       Impact factor: 5.422

2.  Crystal structure of RNA-DNA duplex provides insight into conformational changes induced by RNase H binding.

Authors:  Ryan R Davis; Nadine M Shaban; Fred W Perrino; Thomas Hollis
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Connections between antiviral defense and autoimmunity.

Authors:  Daniel B Stetson
Journal:  Curr Opin Immunol       Date:  2009-06-03       Impact factor: 7.486

4.  Recessive developmental delay, small stature, microcephaly and brain calcifications with locus on chromosome 2.

Authors:  Anna Rajab; Kimberly A Aldinger; Hisham Ali El-Shirbini; William B Dobyns; M Elizabeth Ross
Journal:  Am J Med Genet A       Date:  2009-02       Impact factor: 2.802

5.  Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection.

Authors:  Luna Alammar; Lucio Gama; Janice E Clements
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

Review 6.  Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Authors:  M J Hofer; I L Campbell
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

Review 7.  An Update on Autoinflammatory Diseases: Interferonopathies.

Authors:  Sophia Davidson; Annemarie Steiner; Cassandra R Harapas; Seth L Masters
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 8.  Type I Interferons in NeuroHIV.

Authors:  Victoria E Thaney; Marcus Kaul
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

9.  The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.

Authors:  Markus J Hofer; Wen Li; Sue Ling Lim; Iain L Campbell
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 10.  New roles for the major human 3'-5' exonuclease TREX1 in human disease.

Authors:  David Kavanagh; Dirk Spitzer; Parul H Kothari; Aisha Shaikh; M Kathryn Liszewski; Anna Richards; John P Atkinson
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.